01 8Ranexa
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2020 Revenue in Millions : 9
2019 Revenue in Millions : 216
Growth (%) : -96
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 10
2020 Revenue in Millions : 9
Growth (%) : 11
Main Therapeutic Indication : Cardiovascular
Currency : USD
2015 Revenue in Millions : 510
2014 Revenue in Millions : 588
Growth (%) : 15%
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2016 Revenue in Millions : 677
2015 Revenue in Millions : 588
Growth (%) : 15
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2017 Revenue in Millions : 717
2016 Revenue in Millions : 677
Growth (%) : 6
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2018 Revenue in Millions : 758
2017 Revenue in Millions : 717
Growth (%) : 6%
Main Therapeutic Indication : Cardiovascular
Currency : USD
2014 Revenue in Millions : 13.60%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2019 Revenue in Millions : 216
2018 Revenue in Millions : 758
Growth (%) : -72
LOOKING FOR A SUPPLIER?